Lasa Supergenerics: Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended 31St December 2025

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025.2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.